Aug 3 (Reuters) - Ambu A/S AMBUb.CO :
* REG-PRELIMINARY RESULTS FOR Q3 2021/22, CURRENT TRADING
(JULY)
AND LAUNCH OF COST REDUCTION PROGRAM. FULL-YEAR 2021/22 GUIDANCE
REVISED
* FY 21/22 GUIDANCE REVISED TO ORGANIC REVENUE GROWTH OF NO
LESS
THAN 4% (PREVIOUSLY 13%+)
* FY 21/22 GUIDANCE REVISED TO EBIT MARGIN BEFORE SPECIAL
ITEMS OF
NO LESS THAN 2% (PREVIOUSLY EBIT MARGIN 5%+).
* Q3 REVENUE WAS DKK 1,128M (DKK 973M) BASED ON ORGANIC
GROWTH OF
8% (7%); REPORTED GROWTH WAS 16% (3%)
* Q3 EBIT BEFORE SPECIAL ITEMS WAS AT DKK 42M (DKK 88M)
* GROSS MARGIN FOR Q3 WAS 55.8% (62.5%); FOR FIRST NINE
MONTHS OF
YEAR, GROSS MARGIN WAS 58.2% (63.4%)
* COST REDUCTION PROGRAM IS EXPECTED TO RESULT IN AN
ANNUALISED
IMPACT OF DKK 250M PRE-TAX SAVINGS FROM FINANCIAL YEAR 2022/23.
* QTRLY EBIT AFTER SPECIAL ITEMS WAS AT DKK 29M (DKK 88M)
* COST REDUCTION PROGRAM WILL CORRESPOND TO A REDUCTION OF
APPROXIMATELY 200 EMPLOYEES FROM OUR GLOBAL WORKFORCE
Source text for Eikon: ID:nGNE6PgmmB
Further company coverage: AMBUb.CO
((Reuters.Briefs@thomsonreuters.com;))